Indication:
Fatty liver, jaundice, Infeetious hepatitis, Drug-induced hepatitis, liver discaase, liver cirrhosis, Toxcity of narcotics
Fatty liver, jaundice, Infeetious hepatitis, Drug-induced hepatitis, liver discaase, liver cirrhosis, Toxcity of narcotics
Therapeutic Class: Silymarin
Type: Capsule
Type: Capsule
(Ay) Laboratories
